LAWRENCE, Mass., April 7, 2016 /PRNewswire/ -- Thirteen
people die every day in the United
States waiting for a kidney transplant, most waiting seven
to nine years, according to the U.S. Department of Health and Human
Services. April is National Donate Life Month and NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical
technology company focused on advancing renal care, is joining
forces with MatchingDonors.com, the nation's largest nonprofit
living organ donation website that provides people with an active
way to search for an altruistic live donor. The organizations are
teaming up to raise awareness of treatment options and services
that may help kidney patients receive a transplant.
Houston-area resident and
NxStage® System One™ patient Mary
Raines' life was transformed because of a kidney she
received from an altruistic donor she found with
MatchingDonors.com. Wisconsin
native Elizabeth Meyer gave one of
her kidneys to Mary, a complete stranger, after reading her
inspiring story. In a study conducted by the Chronic Disease
Research Group, patients receiving more frequent, home hemodialysis
(HHD) with the NxStage System One were more likely to receive a
kidney transplant when compared with conventional thrice-weekly
dialysis.
"I attribute much of my good health and ability to get a
transplant to more frequent home hemodialysis with NxStage, which
also gave me and my husband more freedom and more time together,"
said Raines. "I'm also forever grateful to MatchingDonors.com for
helping me connect with an amazing donor who saved my life."
The organizations are educating their respective networks of
kidney disease patients through joint education materials and
communication programs to highlight the underutilization of HHD as
a treatment option while patients are waiting for a transplant with
MatchingDonors.com as a resource for patients seeking a living
donor.
"NxStage is aligning with MatchingDonors.com because organ
donation is an important issue that impacts over 100,000 people
waiting for a kidney transplant, according to the U.S. Department
of Health and Human Services," said Joseph
Turk, President of NxStage. "NxStage is committed to helping
kidney patients reclaim their lives, live longer and be more likely
to receive a transplant."
Go to MatchingDonors.com to learn more about altruistic living
organ donation, and visit NxStage.com for more information about
HHD with the NxStage System One.
Despite the health benefits that home hemodialysis may
provide to those with chronic kidney disease, this form of therapy
is not for everyone. The reported benefits of home hemodialysis may
not be experienced by all patients. The risks associated with
hemodialysis treatments in any environment include, but are not
limited to, high blood pressure, fluid overload, low blood
pressure, heart-related issues, and vascular access complications.
The medical devices used in hemodialysis therapies may add
additional risks including air entering the bloodstream and blood
loss due to clotting or accidental disconnection of the blood
tubing set. Certain risks are unique to the home. Treatments at
home are done without the presence of medical personnel and on-site
technical support. Patients and their partners must be trained on
what to do and how to get medical or technical help if
needed.
About MatchingDonors.com
MatchingDonors.com is the
nation's largest living organ donor organization. The 501(c)3
nonprofit gives people in need of transplant surgery an active way
to search for an altruistic live donor. MatchingDonors.com is
committed to increasing the number of transplant surgeries and
improving awareness of live organ donation. The organization is
supported by memberships, advertisements and donations. On average,
twenty-two people die every day in the United States waiting for a
transplant, many waiting more than five years. Since the inception
of MatchingDonors.com, directed living organ donations has
increased to historic numbers and there are currently more than
14,500 registered potential donors on the site. The average
patient gets their transplant within six months of
signing up on the website. For more information on organ donation
and others ways to help, visit www.MatchingDonors.com.
About the NxStage System One
The NxStage System One is
the first and only truly portable hemodialysis system cleared
specifically by the FDA for home hemodialysis and home
nocturnal hemodialysis. Its simplicity and revolutionary size (just
over a foot tall) are intended to allow convenient use in patients'
homes and give patients the freedom to travel with their therapy.
When combined with the NxStage PureFlow SL Dialysis Preparation
System, patients are able to further simplify, using ordinary tap
water to create dialysis fluid on demand. Unlike conventional
hemodialysis systems, the System One requires no special
infrastructure to operate. Under the guidance of their physician,
patients can use the NxStage System One, with their trained
partners, where, how and when it best meets their needs, including
while they are sleeping - at home or on vacation and at a medically
appropriate treatment frequency. In addition, NxStage's Nx2me
Connected Health platform collects important NxStage System One and
patient information for flexible viewing, monitoring and
reporting that may improve patient management and simplify
alternative site care. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical, Inc.
(Nasdaq: NXTM) is a leading medical technology company,
headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. NxStage
also has established a small number of dialysis clinics committed
to the development of innovative care delivery models for patients
with ESRD. For more information on NxStage and its products and
services, please visit the Company's websites
at www.nxstage.com and www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including the Annual Report on Form 10-K for the year
ended December 31, 2015. NxStage is
under no obligation to (and expressly disclaims any such obligation
to) update or alter its forward-looking statements, whether as a
result of new information, future events or otherwise.
CONTACT: Kristen Sheppard,
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/national-donate-life-month-nxstage-teams-up-with-organ-donation-nonprofit-matchingdonorscom-300247640.html
SOURCE NxStage Medical, Inc.